RP
ABBV icon

Rice Partnership’s AbbVie ABBV Stock Holding History

Rice Partnership’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Sell
1,713
-112
-6% -$24.1K 0.05% 91
2026
Q1 		$397K Sell
1,825
-180
-9% -$39.9K 0.05% 89
2025
Q4 		$458K Buy
2,005
+149
+8% +$33.9K 0.06% 81
2025
Q3 		$430K Buy
1,856
+18
+1% +$3.67K 0.06% 81
2025
Q2 		$341K Sell
1,838
-128
-7% -$23.8K 0.06% 90
2025
Q1 		$412K Sell
1,966
-2,462
-56% -$479K 0.08% 73
2024
Q4 		$787K Sell
4,428
-95
-2% -$17.5K 0.15% 59
2024
Q3 		$893K Buy
4,523
+614
+16% +$115K 0.18% 56
2024
Q2 		$670K Sell
3,909
-102
-3% -$16.9K 0.15% 59
2024
Q1 		$730K Buy
4,011
+360
+10% +$62K 0.17% 59
2023
Q4 		$566K Buy
3,651
+9
+0.2% +$1.31K 0.15% 64
2023
Q3 		$543K Hold
3,642
– – 0.15% 66
2023
Q2 		$491K Sell
3,642
-60
-2% -$8.8K 0.13% 70
2023
Q1 		$590K Hold
3,702
– – 0.18% 66
2022
Q4 		$598K Buy
+3,702
New +$568K 0.19% 65
2021
Q3 		– Sell
-2,379
Closed -$268K – 130
2021
Q2 		$268K Buy
2,379
+491
+26% +$55.3K 0.08% 84
2021
Q1 		$204K Sell
1,888
-60
-3% -$6.42K 0.07% 87
2020
Q4 		$209K Buy
+1,948
New +$187K 0.08% 82

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rice Partnership's ABBV Position: Q2 2026 in Review

Rice Partnership reduced its AbbVie (ABBV) stake by 6.1% in Q2 2026, selling an estimated $24.1K and leaving 1,713 shares worth $431K. The position accounts for 0.05% of the portfolio, ranked #91.

Rice Partnership first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. The position peaked at $893K in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rice Partnership held 1,713 shares of AbbVie worth $431K as of Q2 2026.
  • Rice Partnership sold 112 AbbVie shares in Q2 2026, an estimated $24.1K.
  • AbbVie made up 0.05% of Rice Partnership's portfolio in Q2 2026, its #91 holding.
  • Rice Partnership first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
  • Rice Partnership's AbbVie position peaked at $893K in Q3 2024.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rice Partnership's 13F filing for Q2 2026, filed 29 Jul 2026.